| Analysis | Metabolite Name | Measured Value | Units | gender |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 190612 | Peak area | Male |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 213268 | Peak area | Female |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 221550 | Peak area | Male |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 222655 | Peak area | Male |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 245982 | Peak area | Male |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 250648 | Peak area | Female |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 277018 | Peak area | Female |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 303450 | Peak area | Female |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 318077 | Peak area | Male |
| Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | Peak area | Male | |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 158551 | Peak area | Male |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 189797 | Peak area | Male |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 190362 | Peak area | Female |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 198609 | Peak area | Male |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 200417 | Peak area | Female |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 206606 | Peak area | Male |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 207331 | Peak area | Female |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 207524 | Peak area | Male |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 232638 | Peak area | Male |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 236279 | Peak area | Male |
| Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 247983 | Peak area | Female |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|